Ready 8-Ks
2
Latest filing
September 2, 2026, 4:17 PM ET
Top materiality
0.80
Event mix
earnings ×1 · other_material ×1
Sentiment
2 pos · 0 neg · 0 neu
Recent 8-K filings for ATTO
Highest-materiality recent filing
Attovia Q2 2026 net loss $20.7M; ATTO-1310 proof-of-concept; IPO funds runway to 2030
- Q2 2026 net loss $20.7M vs $14.4M year ago; R&D $18.9M vs $13.6M; collaboration revenue $0.5M.
- Cash $115.1M at 6/30/26; plus $305.4M net IPO proceeds (Aug '26) extends runway into 2030.
-
Attovia Q2 2026 net loss $20.7M; ATTO-1310 proof-of-concept; IPO funds runway to 2030
Q2 2026 net loss $20.7M vs $14.4M year ago; R&D $18.9M vs $13.6M; collaboration revenue $0.5M.
-
Attovia Therapeutics closes IPO, adopts amended charter and bylaws
IPO closed on August 6, 2026; amended charter and bylaws became effective.
Materiality & sentiment trend
Max materiality 0.80 · Median 0.75 · Most common event earnings